Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | — | — | $5.77M | $10.4M | $14.6M |
| Revenue growth | — | — | — | 80.7% | 40.3% |
| Gross profit | — | — | $3.83M | $7.18M | $7.36M |
| Gross margin | — | — | 66.5% | 68.9% | 50.3% |
| Operating income | — | -$3.59M | -$1.87M | -$62.2M | -$9.58M |
| Operating margin | — | — | -32.5% | -596.4% | -65.6% |
| Net income | — | -$3.24M | -$3.76M | -$57.7M | -$14.7M |
| Net margin | — | — | -65.3% | -553.7% | -100.6% |
| EPS (diluted) | — | -$0.25 | -$0.38 | -$5.65 | -$0.73 |
| Fiscal year | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Operating cash flow | — | -$1.39M | -$633K | -$5.79M | -$3.45M |
| Capital expenditures | — | — | $4.33K | $55.3K | $29.9K |
| Free cash flow | — | — | -$637K | -$5.84M | -$3.48M |
| Share buybacks | — | $110M | $6.80M | $5.15K | $44.00 |
| Fiscal year | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Cash & equivalents | $760K | $107K | $119K | $326K | $5.27M |
| Total assets | $118M | $7.63M | $806K | $20.0M | $22.4M |
| Total liabilities | $4.55M | $7.67M | $3.92M | $20.0M | $17.0M |
| Long-term debt | — | — | $220K | $594K | $594K |
| Shareholders' equity | -$3.33M | -$574K | -$4.30M | -$18.5K | $5.45M |
| Retained earnings | -$3.33M | -$6.24M | -$6.76M | -$67.7M | -$82.4M |
| Shares (wtd avg diluted) | — | 12.7M | 10.00M | 10.2M | 20.1M |
Every figure is extracted from VSEE HEALTH, INC.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.